Is Insulin Lispro Injection (Humalog Tempo Pen) in shortage?
Insulin Lispro Injection is listed by FDA as being discontinued by at least one maker (updated Sep 1, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05)
A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.
Maker contact: 800-545-5979
- Humalog, Injection, U-100 Tempo Pen (NDC 0002-8213-05)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 800-545-5979
FDA recalls of Insulin Lispro
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Insulin Lispro Injection:
- Eli Lilly & Company recalls Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin
- Sanofi-Aventis U.S. LLC recalls Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC,
- Cardinal Health Inc. recalls Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly
- Sanofi-Aventis U.S. LLC recalls Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per
Other forms on FDA’s list
Insulin Lispro Injection shortage questions
Is Insulin Lispro Injection (Humalog Tempo Pen) in shortage?
Insulin Lispro Injection is listed by FDA as being discontinued by at least one maker (updated Sep 1, 2026).
What should I do if I can’t get Insulin Lispro Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.